MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program
Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Gains ‘Strong Foothold’ in California’s Central Valley on Newly Named Dealer
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has added Affinity Truck Center, a family-owned business founded in 1980, to its retail network. As a result, Affinity, which operates sales locations in Bakersfield and Fresno, California, as well as service locations in Paso Robles and Salinas,…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has named a seasoned medtech leader as its new chief financial officer. According to the announcement, Timothy Cruickshank has accepted the role of chief financial officer, effective immediately; he succeeds Richard Brounstein, who announced his retirement. Cruickshank…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Featured Guest on Latest Episode of BioMedWire Podcast
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is spotlighted in this week’s episode of The BioMedWire Podcast. During the episode, Scinai Immunotherapeutics CEO Amir Reichman talks with host Carmel Fisher about SCNI’s…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Achieves ‘Important Accomplishment’ with CARB Certification
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has received certification from the California Air Resources Board (“CARB”) for its B4 all-electric, Class 4 low forward chassis truck. The CARB certification is a requirement to sell vehicles in California, Colorado, Connecticut, Delaware, Maine, Maryland, Massachusetts, New…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device and Pharmaceutical Industries Veteran as New CEO
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024. Mr. Christopher is a recognized industry veteran with over three decades of experience in the medical device and pharmaceutical industries. He has domestic and international experience in leadership,…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced participation at the H.C. Wainwright 26th Annual Global Investment Conference. The conference, held virtually and in person, is scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel in New…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming H.C. Wainwright 26th Annual Global Investment Conference. The event is slated for Sept. 9–11, 2024, in New York. According to the announcement, CEO…
-
MissionIRNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific Advisor
Telomir Pharmaceuticals (NASDAQ: TELO), a pre-clinical-stage company seeking to lead developments in longevity science through the treatment of age-related conditions, today announced the appointment of Dr. Itzchak Angel as Chief Scientific Advisor. Dr. Angel’s extensive career in pharmaceutical innovation spans over 40 years, during which he has been instrumental in the research, development, and regulatory…
-
MissionIRNewsBreaks – WiSA Technologies, Inc. (NASDAQ: WISA) Executes Definitive Agreement to Create ‘Larger, More Dynamic Entity’ with Broad Reach
WiSA Technologies (NASDAQ: WISA) today announced the execution of a definitive asset purchase agreement to purchase the Datavault(R) intellectual property and information technology assets of privately held Data Vault Holdings Inc. WiSA will pay $210 million as consideration, consisting of 40 million shares of common stock to be issued at $5 per share plus a…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Provides Update on Its Iska Iska Silver-Tin Polymetallic Project in Southwestern Bolivia
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, today provided an update on its Iska Iska silver-tin polymetallic project in Potosi Department, southern Bolivia. According to the update, an initial program of 5,700m of diamond drilling…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Additional Orders from European Governments Totaling $2.6M
SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has received new orders valued at $2.6 million from different governments in Europe; the company anticipates fulfilling the orders in the next three months. The company offers PureSecurity Suite, an end-to-end electronic monitoring solution that features state-of-the-art GPS tracking,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical setting. Lexaria will be responsible for formulating and supplying certain DehydraTECH compositions, with the pharmaceutical…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Management to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company today announced that its management will present at the H.C.…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth
InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset,…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Expands Team in Continued Focus to Make Meaningful Impact on Lives of AD, PD Patients
Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), recently welcomed four seasoned professionals to its executive team. “Annovis Bio is excited about the new additions and confident that these highly experienced professionals will significantly contribute to…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation. “With its unique market positioning, Correlate is facilitating the global solar energy transition, offering important additional benefits associated with its adoption, encouraging profitability and overall…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Expands National Dealer Network Westward with 20 Locations
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing that its subsidiary, Bollinger Motors, has added TEC Equipment, Inc. to its sales and service network. The move, which adds 20 select sales and service locations, expands the subsidiary’s commercial EV dealer network across all key markets in the Western United States. The…
-
MissionIRNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Launches Comprehensive B2B Marketing Campaign to Drive Sales Growth into 2025
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a provider of next-generation transdermal alcohol detection solutions, today announced the launch of a new national campaign to introduce the SOBRsafe(TM) technology to behavioral health providers and drive sales growth into 2025. The comprehensive B2B campaign involves partnerships with prominent national agencies across public relations and digital and social media…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces ‘Landmark Agreement’ Providing Exposure to the UAE, Middle East
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a contract worth approximately $210 million. According to the announcement, Volt Mobility, a leading United Arab Emirates (“UAE”)-based commercial leasing company, has entered into a purchase agreement to acquire 3,000 Class 1 and Class 3 EV cargo vans and trucks over a 16-month…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Begin Trading as Solmate (NASDAQ: SLMT) on Oct. 3
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Builds Domestic Supply Chain Using RapidSX Technology
- Forward Industries Inc. (NASDAQ: FORD) Is ‘One to Watch’
- MissionIRNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Signs Agreement to Supply Mullen EVs for FedEx ISP Fleets
- MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Sets Standard in High-Performance E-Boat Space